Credit Agricole
CLVS

Credit Agricole’s Clovis Oncology, Inc. CLVS Stock Holding History

Credit Agricole’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-19,500
Closed -$1.61M – 1180
2017
Q3 		$1.61M Buy
19,500
+19,000
+3,800% +$1.51M 0.01% 971
2017
Q2 		$47K Buy
+500
New +$30.6K ﹤0.01% 1385
2016
Q2 		– Sell
-4,344
Closed -$83K – 1533
2016
Q1 		$83K Buy
+4,344
New +$91.9K ﹤0.01% 1192
2014
Q2 		– Sell
-2,300
Closed -$159K – 1677
2014
Q1 		$159K Buy
+2,300
New +$169K ﹤0.01% 1306

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return